Ticker

ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, today reported first quarter 2026 results. “I am so pleased with our team's performance across the business helping get us off to a very strong start despite very challenging retail and wholesale environments in the leisure markets we serve. Our focus for the last…

PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc., Lanexa Biologics, a wholly owned subsidiary of Lannett, and Sunshine Lake Pharma today announced that the U.S. Food and Drug Administration (FDA) has approved LANGLARA™ (insulin glargine-aldy), as a biosimilar to Lantus® (insulin glargine), for the treatment of adults and pediatric patients with type 1 diabetes mellitus and adults with type 2 diabetes mellitus.…

ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII) today announced that the company and Patrick Industries (NASDAQ: PATK) have terminated discussions regarding a potential merger of equals, as the companies were unable to reach mutually agreeable terms. LCI Industries and Patrick Industries each previously confirmed discussions on April 17 and noted there could be no assurance that any such agreement would…

ELKHART, Ind., May 4, 2026 /PRNewswire/ -- Patrick Industries, Inc. (NASDAQ: PATK) ("Patrick" or the "Company"), a leading component solutions provider for the Outdoor Enthusiast and Housing markets, today announced that the Company and LCI Industries (NYSE: LCII) have terminated discussions regarding a potential business combination.

ELKHART, Ind.--(BUSINESS WIRE)--LCI Industries (NYSE: LCII) today confirmed that it is in discussions with Patrick Industries, Inc. (NASDAQ: PATK) regarding a possible merger of equals. These discussions are ongoing, and there can be no assurances that such discussions will result in a transaction or on what terms any transaction may occur. LCI Industries does not intend to comment further unless and until it…